Aging and sexuality in women;Invecchiamento e sessualità nelle donne

Minerva Ginecologica

Volumn 59, Issue 3, 2007, Pages 287-298

  Nappi, R E ^a   Albani, F ^a   Valentino, V ^b   Polatti, F ^a   Chiovato, L ^a   Genazzani, A R ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Aged; Sexuality; Women

Indexed keywords

ANDROGEN; ESTROGEN; TIBOLONE;

AGING; ANDROGEN BLOOD LEVEL; FEMALE SEXUAL DYSFUNCTION; HUMAN; MENOPAUSE; ORGASM; QUALITY OF LIFE; REVIEW; SEXUAL BEHAVIOR; SEXUAL COUNSELING; SEXUAL SATISFACTION; SEXUALITY; WELLBEING; WOMEN'S HEALTH;

AGING; AROUSAL; COUNSELING; DRUG THERAPY, COMBINATION; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; LIBIDO; LIFE STYLE; MENOPAUSE; NORPREGNENES; PERSONALITY; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TESTOSTERONE; TREATMENT OUTCOME;

EID: 34547653959     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Nappi RE, Polatti F. Menopausa e sessualità. In: Genazzani AR, Gambacciani M editors. Premenopausa e menopausa. Roma: CIC Edizioni Internazionali; 2000. p. 165-84.
2. Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J et al. Report of the Interational Consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000;163:888-93.
3. Dennerstein L, Randolph J, Taffe J, Dudley E, Burger H. Hormones, mood, sexuality, and the menopausal transition. Fertil Steril 2002;77:S42-8.
4. Bachmann GA, Leiblum SR. The impact of hormones on menopausal sexuality: a literature review. Menopause 2004;11:120-30.
5. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000;96:351-8.
6. Castelo-Branco C, Blumel JE, Araya H, Riquelme R, Castro G, Haya J et al. Prevalence of sexual dysfunction in a cohort of middle-aged women: influences of menopause and hormone replacement therapy. J Obstet Gynaecol 2003;23:426-30.
7. Blumel JE, Castelo-Branco C, Cancelo MJ, Romero H, Aprikian D, Sarra S. Impairment of sexual activity in middle-aged women in Chile. Menopause 2004;11:78-81.
8. Nappi RE, Nijland EA. Women's perception of sexuality around the menopause: outcomes of a European telephone survey. Eur J Obstet Gynecol Reprod Biol 2007 Jan 3; [Epub ahead of print].
9. Nappi RE, Baldaro Verde J, Polatti F, Genazzani AR, Zara C. Self-reported sexual symptoms in women attending menopause clinics. J Obstet Gynecol Invest 2002;53:181-7.
10. Bachmann GA, Leiblum SR. Sexuality in sexagenarian women. Maturitas 1991;13:43-50.
11. Nicolosi A, Laumann EO, Glasser DB, Moreira ED Jr, Paik A, Gingell C. Global Study of Sexual Attitudes and Behaviors Investigators' Group. Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors. Urology 2004;64:991-7.
12. Dennerstein L, Koochaki P, Barton I, Graziottin A. Hypoactive sexual desire disorder in menopausal women: a survey of western European women. J Sex Med 2006;3:212-22.
13. Leiblum S, Koochaki P, Rodenberg C, Barton I, Rosen RC. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause 2006;13:46-56.
14. Meston CM, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry 2000;57:1012-30.
15. Rosen R, Bachmann G, Leiblum S. Androgen insufficiency in women: the Princeton Conference. Fertil Steril 2002;77 Suppl 4.
16. McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocr Rev 1999;20:279-307.
17. Sarrel PM. Sexuality and menopause. Obstet Gynecol 1990;75:S26-5.
18. Munarriz R, Kim NN, Goldstein I, Traish AM. Biology of female sexual function. Urol Clin North Am 2002;29:685-93.
19. Nappi RE. Sexuality and menopause. In: Erkkola R editor. The menopause. Philadelphia, PA: Elsevier; 2006. p. 143-54.
20. Nappi RE, Detaddei S, Ferdeghini F, Brundu B, Sommacal A, Polatti F. Role of testosterone in feminine sexuality. J Endocrinol Invest 2003;26:97-101.
21. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005;90:3847-53.
22. Labrie F, Luu-The V, Belanger A, Lin SX, Simard J, Pelletier G et al. Is dehydroepiandrosterone a hormone? J Endocrinol 2005;187:169-96.
23. Lobo RA. Androgens in postmenopausal women: production, possible role, and replacement options. Obstet Gynecol Surv 2001;56:361-76.
24. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, von Muhlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 2000;85:645-51.
25. Farquhar CM, Sadler L, Harvey SA, Stewart AW. The association of hysterectomy and menopause: a prospective cohort study. Br J Obstet Gynecol 2005;112:956-62.
26. Nappi RE, Wawra K, Schmitt S. Hypoactive sexual desire disorder in postmenopausal women. Gynecol Endocrinol 2006;22:318-23.
27. Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA 2005;294:91-6.
28. Guay A, Davis SR Testosterone insufficiency in women: fact or fiction? World J Urol 2002;20: 106-10.
29. Frye CA, Bayon LE, Pursnani NK, Purdy RH. The neurosteroids, progesterone and 3(,5(-THP, enhance sexual motivation, receptivity, and proceptivity in female rats. Brain Res 1998;808:72-83.
30. Sarrel PM. Effects of hormone replacement therapy on sexual psychophysiology and behaviour in postmenopause. J Womens Health Gend Based Med 2000;9:S25-32.
31. Nappi R, Salonia A, Traish AM, van Lunsen RH, Vardi Y, Kodiglu A et al. Clinical biologic pathophysiologies of women's sexual dysfunction. J Sex Med 2005;2:4-25.
32. Basson R, Schultz WW. Sexual sequelae of general medical disorders. Lancet 2007;369:409-24.
33. Enzlin P, Mauhieu C, Vanderschueren D, Demyttenaere K. Diabetes mellitus and female sexuality: a review of 25 years' research. Diabet Med 1998;15:809-15.
34. Salonia A, Lanzi R, Scavini M, Pontillo M, Gatti E, Petrella G et al. Sexual function and endocrine profile in fertile women with type 1 diabetes. Diabetes Care 2006;29:312-6.
35. Bhasin S, Enzlin P, Coviello A, Basson R. Sexual dysfunction in men and women with endocrine disorders. Lancet 2007;369:597-611.
36. Doumas M, Tsiodras S, Tsakiris A, Douma S, Chounta A, Papadopoulos A et al. Female sexual dysfunction in essential hypertension: a common problem being uncovered. J Hypertens 2006;24:2387-92.
37. Fogari R, Preti P, Zoppi A, Corradi L, Pasotti C, Rinaldi A et al. Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women. Am J Hypertens 2004;17:77-81.
38. Park K, Tarcan T, Goldstein I, Siroky MB, Krane RJ, Azadzoi KM. Atherosclerosis-induced chronic arterial insufficiency causes clitoral cavernosal fibrosis in the rabbit. Int J Impot Res 2000;12:111-6.
39. Thomas TM, Plymat KR, Blannin J, Meade TW. Prevalence of urinary incontinence. Br Med J 1980;281:1243-8.
40. Hilton P. Urinary incontinence during sexual intercourse: a common but rarely volunteered symptom. Br J Obstet Gynecol 1988;95:377-81.
41. Gordon D, Groutz A, Sinai T, Wiezman A, Lessing JB, David MP et al. Sexual function in women attending a urogynecology clinic. Int Urogynecol J Pelvic Floor Dysfunct 1999;10:325-8.
42. Salonia A, Zanni G, Nappi RE, Briganti A, Deho F, Fabbri F et al. Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study. Eur Urol 2004;45:642-8.
43. Clayton AH. Female sexual dysfunction related to depression and antidepressant medications. Curr Womens Health Rep 2002;2:182-7.
44. Cioffi L, De Placido G, Fusco F, Mirone V, Montorsi F, Nappi RE et al. Le disfunzioni sessuali femminili. Pisa: Pacini; 2003.
45. Farrell SA, Kieser K. Sexuality after hysterectomy. Obstet Gynecol 2000;95:1045-51.
46. Khastgir G, Studd J. Patients' outlook, experience, and satisfaction with hysterectomy, bilateral oophorectomy, and subsequent continuation of hormone replacement therapy. Am J Obstet Gynecol 2000;183:1427-33.
47. Lonnee-Hoffmann RA, Schei B, Eriksson NH. Sexual experience of partners after hysterectomy, comparing subtotal with total abdominal hysterectomy. Acta Obstet Gynecol Scand 2006;85:1389-94.
48. Bradford A, Meston C. Sexual outcomes and satisfaction with hysterectomy: influence of patient education. J Sex Med 2007;4:106-14.
49. Ganz PA. Sexual functioning after breast cancer: a conceptual framework for future studies. Ann Oncol 1997:8:105-7.
50. Wilmoth MC, Ross JA. Women's perception. Breast cancer treatment and sexuality. Cancer Pract 1997;5:353-9.
51. Mortimer JE, Boucher L, Baty J, Knapp DL, Ryan E, Rowland JH. Effect of tamoxifen on sexual functioning in patients with breast cancer. J Clin Oncol 1999;17:1488-92.
52. Berglund G, Nystedt M, Bolund C, Sjoden PO, Rutquist LE. Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: a prospective randomized study. J Clin Oncol 2001;19:2788-96.
53. Nappi RE, Salonia A. Menopausa e sessualità/2. Roma: CIC Ed. Intemazionali; 2004.
54. Plaut SM, Graziottin A, Heaton JPW. Sexual Dysfunction. Oxford, UK: Health Press; 2004.
55. Alexander JL, Kotz K, Dennerstein L, Kutner SJ, Wallen K, Notelovitz M. The effects of postmenopausal hormone therapies on female sexual functioning: a review of double-blind, randomized controlled trials. Menopause 2004;11:749-65.
56. Modelska K, Cummings S. Female sexual dysfunction in postmenopausal women: systematic review of placebo-controlled trials. Am J Obstet Gynecol 2003;188:286-93.
57. Dennerstein L, Lehert P, Burger H. The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition. Fertil Steril 2005;84:174-80.
58. Shifren J, Braunstein G, Simon J, Casson PR, Buster JE, Redmond GP et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682-8.
59. Davis S, Tran J. Testosterone influences libido and well-being in women. Trends Endocrinol Metab 2001;12:33-7.
60. Braunstein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med 2005;165:1582-9.
61. Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005;90:5226-33.
62. Buster JE, Kingsberg SA, Aguirre O, Brown C, Breaux JG, Buch A et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 2005;105:944-52.
63. Shifren JL, Davis SR, Moreau M, Waldbaum A, Bouchard C, DeRogatis L et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause 2006;13:770-9.
64. Davis SR. The effects of tibolone on mood and libido. Menopause 2002;9:162-70.
65. Nappi RE, Ferdeghini F, Sampaolo P, Vaccaro P, De Leonardis C, Albani F et al. Clitoral circulation in postmenopausal women with sexual dysfunction: a pilot randomized study with hormone therapy. Maturitas 2006;55:288-95.
66. Doren M, Rubig A, Coelnigh Bennink HK, Holzgreve W. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. Fertil Steril 2001;75:554-9.
67. Castelo-Branco C, Vicente JJ, Figueras F, Sanjuan A, Martinez de Osaba MJ, Casals E et al. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women. Maturitas 2000;34:161-8.
68. Pinkerton JV, Shifren JL, La Valleur J, Rosen A, Roesinger M, Siddhanti S. Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women. Menopause 2003;10:45-52.
69. Parsons A, Merritt D, Rosen A, Heath H 3rd, Siddhanti S, Plouffe L Jr. Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy. Obstet Gynecol 2003;101:346-52.
70. Morales AJ, Nolan JJ, Nelson JC, Yen SSC. Effects of a replacement dose of dehydroepiandrosterone in men and women of advanced age. J Clin Endocrinol Metab 1994;78:1360-7.
71. Wright J, Naftolin F, Schneider HP, Sturdee DW; Executive Committee of the International Menopause Society. Guidelines for the hormone treatment of women in the menopausal transition and beyond. Position statement by the Executive Committee of the International Menopause Society. Maturitas 2004;48:27-31.
72. Castelo-Branco C, Cancelo MJ, Villero J, Nohales F, Julia MD. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas 2005;52:S46-52.
73. Rioux JE, Devlin C, Gelfand MM, Steinberg WM, Hepburn DS. 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis. Menopause 2000;7:156-61.
74. Dugal R, Hesla K, Sordal T, Aase KH, Lilleeidet O, Wickstrom E. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy. Acta Obstet Gynecol Scand 2000;79:293-7.
75. Basson R. Pharmacotherapy for sexual dysfunction in women. Expert Opin Pharmacother 2004;5:1045-59.
76. Basson R. Introduction to special issue on women's sexuality and outline of assessment of sexual problems. Menopause 2004;11:709-13.
77. Basson R. Hormones and sexuality: current complexities and future directions. Maturitas 2007 Mar 14; [Epub ahead of print].